Key facts
- Notable investors include Changxing Fund, Jilin Investment Group, Jilin Province Technology Investment Fund.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Changchun Senohesi Biomedical Materials
- ·The full record, as it builds
Funding rounds
No funding rounds for Changchun Senohesi Biomedical Materials are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Changchun Senohesi Biomedical Materials
Manufacturer of ecological and environmental polymer materials intended to produce absorbable sutures. The company offers raw materials, semi-finished products and finished products of class I, II and III medical devices, research and development, catering to clients with bio-based material technology, and development of human gene diagnosis and treatment technology.
- Sector
- Healthcare
- HQ
- Changchun, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Changchun Senohesi Biomedical Materials doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Changchun Senohesi Biomedical Materials shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Changchun Senohesi Biomedical Materials in its N-PORT filings yet. We sweep new filings monthly.